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Abstract
Background: Babesiosis is a protozoal, tick transmitted disease found worldwide in humans, wildlife and
domesticated animals. Commonly used approaches to diagnose babesiosis include microscopic examination of
peripheral blood smears, detection of circulating antibodies and PCR. To screen and differentiate canine Babesia
infections many PCR assays amplify the 18S rRNA gene. These sequences contain hypervariable regions flanked by
highly conserved regions allowing for amplification of a broad-range of Babesia spp. However, differences in the
18S rRNA gene sequence of distantly related clades can make it difficult to design assays that will amplify all
Babesia species while excluding the amplification of other eukaryotes. By targeting Babesia mitochondrial genome
(mtDNA), we designed a novel three primer qPCR with greater sensitivity and broader screening capabilities to
diagnose and differentiate Babesia spp.
Methods: Using 13 Babesia mtDNA sequences, a region spanning two large subunit rRNA gene fragments
(lsu5-lsu4) was aligned to design three primers for use in a qPCR assay (LSU qPCR) capable of amplifying a
wide range of Babesia spp. Plasmid clones were generated and used as standards to determine efficiency,
linear dynamic range and analytical sensitivity. Animals naturally infected with vector-borne pathogens were
tested retrospectively and prospectively to determine relative clinical sensitivity and specificity by comparing
the LSU qPCR to an established 18S rDNA qPCR.
Results: The LSU qPCR efficiencies ranged between 92 and 100% with the limit of detection at five
copies/reaction. The assay did not amplify mammalian host or other vector-borne pathogen gDNA except
Cytauxzoon felis (a feline protozoal pathogen). The LSU qPCR assay amplified 12 different Babesia. sp. and C.
felis from 31/31 (100%) archived samples, whereas the 18S qPCR amplified only 26/31 (83.9%). By prospective
analysis, 19/394 diagnostic accessions (4.8%) were LSU qPCR positive, compared to 11/394 (2.8%) 18S rDNA
qPCR positive.
Conclusions: We have developed a more sensitive qPCR assay with a more expansive range of Babesia spp.
detection by targeting a highly conserved region of mtDNA, when compared to an established 18S qPCR.
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Background
Babesiosis is a protozoal, tick transmitted disease found
worldwide in humans, wildlife and domesticated ani-
mals. Dogs can be infected with a wide range of Babesia
spp., including B. gibsoni, B. vogeli, B. canis, B. rossi, B.
conradae, B. microti-like (also referred to as "Theileria
annae" or "B. vulpes") and several large un-named Babe-
sia spp., designated “B. coco” [1–6]. Clinical signs of ca-
nine babesiosis include thrombocytopenia, anemia,
splenomegaly, fever, and can result in death [7]. Methods
of diagnosing Babesia infections include microscopic
examination of peripheral blood smears, indirect im-
munofluorescent antibody test to detect circulating anti-
bodies and polymerase chain reaction (PCR) to detect
pathogen DNA. Gene targets that have been used to
amplify Babesia DNA include 18S ribosomal RNA, beta-
tubulin, heat shock protein 70 (hsp70), thrombospondin
related adhesive protein gene (P18 or BgTRAP) and two
internal transcribed spacers (ITS1 and ITS2) [8–14].
Amplifying evolutionarily conserved genes, essential for
survival, are often reliable PCR targets for genus-specific
screening assays; however, identifying highly conserved
regions for primer annealing in close proximity to re-
gions of sequence heterogeneity for species discrimin-
ation can be challenging, particularly when including
more distant lineages of Babesia spp. To screen and
differentiate canine Babesia infections, the Vector-Borne
Disease Diagnostic Laboratory at North Carolina State
University (VBDDL-NCSU) has utilized a quantitative
real-time PCR (qPCR) assay designed to amplify a region
of the evolutionarily conserved 18S rRNA gene [15].
Ribosomal DNA sequences contain hypervariable re-
gions, which are frequently used for species-specific
amplification and are flanked by highly conserved re-
gions used for broad-range genus amplification. This ef-
fectively allows amplification and discrimination of most
Babesia species. However, differences in the 18S rRNA
gene sequence of the more distantly related clades,
which include B. conradae and B. microti-like parasites,
make it difficult to design 18S rDNA assays that will
amplify all Babesia species while excluding the amplifi-
cation of other eukaryotes. Therefore, diagnostic labora-
tories often design separate and specific PCR assays to
amplify B. conradae and B. microti-like in dogs where
these pathogens are suspected. Screening for a wide
range of Babesia species using specific primers for each
species creates challenges for high throughput testing
and limits the ability of a laboratory to identify “new”
species that might infect dogs or other domestic and
wild animals. In this study, we set out to design a novel
assay with greater sensitivity and broader screening
capabilities while retaining the ability to differentiate
Babesia spp. This goal was achieved by targeting the
Babesia mitochondrial genome (mtDNA).
Like other Apicomplexa, Babesia mtDNA can be
present in higher copy numbers than the chromosomal
genome and contains evolutionarily conserved genes in-
cluding cytochrome b (cytb), cyclooxygenase (cox) and
large subunit ribosomal DNA (lsu) [16]. Improved sensi-
tivity over the 18S rDNA target has been demonstrated
using mtDNA targets in several Apicomplexa PCR assays,
including Babesia and Theileria spp. [17–22]. To the
authors’ knowledge this report describes the first single
qPCR targeting Babesia mtDNA that amplifies a wide
range of Babesia spp. We describe the development and
validation of a Babesia genus-specific, three primer qPCR
assay targeting the lsu5-lsu4 region of mtDNA. The diag-
nostic utility of this assay (LSU qPCR) was demonstrated
through retrospective and prospective analysis by compar-
ing the sensitivity and specificity to an established 18S
rDNA Babesia genus-specific qPCR using blood samples
from uninfected and naturally-infected animals.
Methods
Samples
Samples of ethylenediamine tetraacetic acid (EDTA)-antic-
oagulated whole blood specimens from various host ani-
mals submitted to the VBDDL-NCSU for research or
diagnostic testing were used to test the sensitivity and spe-
cificity of this assay. Retrospective testing was performed
on archived feline, bovine, canine, equine, and wildlife
samples previously characterized as containing Babesia
spp. (n = 31) to assess sensitivity, and samples containing a
different vector-borne pathogen (n = 13) or samples from
uninfected animals (n = 4) were used to assess specificity.
Archived DNA samples were previously characterized as
uninfected or infected using species-specific PCRs or PCR
amplification and sequence analysis of the V4 hypervariable
region of the Babesia 18S rRNA gene [8]. Six of the cha-
racterized samples were from previously published studies
and included a B. rossi sample, three B. conradae samples
and two B. microti-like samples from grey and red foxes
[23–25]. Samples containing non-Babesia vector-borne
pathogens were confirmed by PCR amplification and
sequencing by the VBDDL-NCSU using species-specific
gene targets and included Anaplasma platys, A. phago-
cytophilum, Bartonella henselae, Cytauxzoon felis, Ehrlichia
canis, E. ewingii, Hepatozoon americanum, H. canis, Leish-
mania infantum, Mycoplasma hemocanis, Neorickettsia
risticii, Rickettsia rickettsii,Theileria equi and Trypanosoma
cruzi. Prospective testing was performed on canine samples
submitted between July 1, 2015 and August 28, 2015 for
vector-borne disease testing (n = 394).
Primers
To design primers better able to detect DNA from known
and emerging Babesia spp., alignments were made be-
tween a wide range of Babesia mtDNA sequences. A
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region spanning two large subunit rRNA gene frag-
ments (lsu5 and lsu4) conserved among Babesia spp.
containing sequence heterogeneity, flanked by areas of
high similarity, was identified as a potential new qPCR
target (Fig. 1) [26–28]. To develop a new Babesia LSU
qPCR (LSU qPCR), three primers (2 forward, 1 reverse;
Table 1) were designed using an alignment of the follow-
ing 13 Babesia mtDNA sequences: B. bovis (AB499088),
B. bigemina (AB499085), B. caballi (AB499086), B. coco
(KC207824), B. canis (KC207822), B. rossi (KC207823), B.
vogeli (KC207825), B. conradae (KC207826), B. divergens
(LK935355), B. gibsoni (AB499087), B. microti-type II
(AB624354), B. microti-type IV (AB624356) and B.
microti-like (KC207827) (Fig. 2). B-lsu-F and B-lsu-R2
were designed to amplify a ~150 bp product from all
Babesia spp. in the alignment except B. microti or B.
microti-like. Bmic-F was designed to amplify a ~230 bp
product from B. microti or B. microti-like when used with
B-lsu-R2 (Figs. 1, 2). For assay comparisons, an established
Babesia genus 18S rDNA qPCR (18S qPCR), utilized by
the VBDDL-NCSU for Babesia molecular diagnostic
detection, was used to amplify a ~200 bp region of the
Babesia 18S rRNA gene with Bcommon_F and Bcom-
mon_R primers (Table 1). Established Babesia species-
specific PCRs using primers designed to anneal to a
hypervariable region of the 18S rRNA gene and newly
designed species-specific cox1 (a gene found on the
mtDNA) primers were used to confirm Babesia species in
LSU qPCR and 18S qPCR positive samples (Table 1).
Initial amplicons generated in both the LSU qPCR and
cox1 species-specific qPCRs from samples containing
known Babesia spp. were sequenced to confirm primers
amplified the correct target DNA for each Babesia species.
Amplicons generated during prospective testing from the
LSU-qPCR but not the 18S qPCR assay (discordant
results) were sequenced.
DNA extraction and PCR conditions
DNA extraction was performed on QIAsymphonySP
(Qiagen, Hilden, Germany) with QIAsymphony® DNA
Mini Kit (192) (Qiagen) or Qiagen BioRobot® M48
Robotic Workstation with MagAttract® DNA Mini M48
kit (Qiagen) depending on the time of sample submis-
sion. DNA was stored at -20 °C until PCR analysis. All
PCR sample preparations were prepared in a biocontain-
ment hood with UV light decontamination capabilities.
The absence of PCR inhibitors was demonstrated by the
amplification of GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) [8]. Amplification reactions for all PCRs
contained 12.5 μl SYBR®Green Supermix (Bio-Rad,
Hercules, USA), 5 μl DNA template, primers at various
concentrations (Table 2) and molecular grade water to a
final volume of 25 μl. Thermocycler conditions were
established based on several factors, which included
using temperature cycles that could be run with other
NCSU-VBDDL qPCR assays, recommendations by Bio-
Rad for use of SYBR®Green Supermix, and calculated
melting temperatures of newly designed primers. Further-
more, gradients for primer annealing temperatures and
concentrations were performed to identify a combination
Fig. 1 Babesia LSU qPCR primers in relation to the mitochondrial DNA genome structure. a a1 Babesia microti (Type-I and Type II orientation) [27]
and B. microti-like [28]; b b1 “typical” Piroplasmida [26]
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Table 1 Primer sequences for Babesia genus and species-specific PCRs
Primer name Gene target Sequence (5′-3′)
B-lsu-F Babesia lsu5-lsu4 ACCTGTCAARTTCCTTCACTAAMTT
B-lsu-R2 Babesia lsu5-lsu4 TCTTAACCCAACTCACGTACCA
Bmic-F B. microti-like lsu5-lsu4 TTGCGATAGTAATAGATTTACTGC
Bcommon-F Babesia 18S rRNA GCATTTGCGATGGACCATTCAAG
Bcommon-R Babesia 18S rRNA CCTGTATTGTTATTTCTTGTCACTACCTC
BMIC18-F B. microti-like 18S rRNA CTGCTTTATCATTAATTTCGCTTCCGAACG
BCV-F B. vogeli 18S rRNA GTTCGAGTTTGCCATTCGTT
BCC-F B. canis 18S rRNA TTGCGTTGACGGTTTGACC
BCO-F B. coco 18S rRNA CCTTTTCTTTGCTTTGTCGC
BGNC-F B. gibsoni 18S rRNA ACTCGGCTACTTGCCTTGTC
BAB722-R Babesia 18S rRNA ATGCCCCCAACCGTTCCTATTA
BCV-cox1-F4 B. vogeli cox1 TGCTATGAGTGGCGCAAATTTTG
BCV-cox1-R B. vogeli cox1 CCATACAGTAGGTATCAATCTATCT
BCC-cox1-F2 B. canis cox1 GTGCAATGAGTGGAGCAAATTTCA
BCC-cox1-R B. canis cox1 CCATACAGTTGGTATTAATCTATCC
BCO-cox1-F2 B. coco cox1 TTGTAACTTCTGTTTTACTTATGGTG
BCO-cox1-R2 B. coco cox1 AAAATAAGAATATAAACCTCAGGATGT
BG-cox1-F B. gibsoni cox1 CTTCAGCCAATAGCTTTCTGTTTG
BG-cox1-R B. gibsoni cox1 CCTGAGGCAAGTAAACCAAATAT
Fig. 2 Sequence alignment of the lsu5-lsu4 region of the mitochondrial DNA from representative Babesia spp. and primers designed for use in
the Babesia LSU qPCR assay. The source of sequence for Babesia spp. are shown in parentheses (GenBank accession numbers or PCR amplicon
sequence). * represents sequences aligned in a reverse complement orientation
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that amplified target DNA efficiently but did not amplify
nonspecific DNA. Thermocycler conditions consisted of
an initial denaturation step at 98 °C for 3 min, followed by
40 cycles at 98 °C for 15 s, 60 °C for 15 s (or 62 °C for B.
microti-like 18S species-specific qPCR), and 72 °C for
15 s. Melting temperature (Tm) measurements were made
between 65 and 88 °C at 0.5 s intervals. All qPCRs in-
cluded a positive control consisting of either a previously
characterized Babesia-infected sample or Babesia plasmid
DNA and negative controls including a no-template con-
trol consisting of filter-sterilized, molecular-grade water
and uninfected dog or cat genomic DNA (gDNA). Newly
extracted samples were tested with DNA extraction
controls. PCR amplification was performed in a C1000™
Thermal Cycler (Bio-Rad) with CFX96™ Real-Time Detec-
tion System. Following PCR, amplicons were analyzed via
the quantification cycle (Cq), melt curve shape and Tm
difference. To validate amplicon size, several PCR prod-
ucts were visualized on a 2.0% agarose gel in 1× TAE with
ethidium bromide staining alongside a DNA molecular
size marker. Sequencing of products or plasmids was
performed by GENEWIZ Inc. (Research Triangle Park,
NC) and alignments made with GenBank reference
sequences using AlignX software (Vector NTI Suite 6.0,
InforMax, Inc.)
qPCR efficiency
Plasmid clones, used as standards for efficiency and ana-
lytical sensitivity determination, were constructed using
LSU qPCR amplicons from B. vogeli, and B. microti-like
template DNA with pGEM-T Easy Vector System
(Promega, Madison, WI) as recommended by the manu-
facturer. Plasmids were sequenced and inserts confirmed
using M13R primers. Plasmid copy numbers were calcu-
lated assuming an average base pair weight of 650 Da and
Avogadro’s number (6.022 1023) using the following
equation: copy number = (DNA ng amount × 6.022 1023
molecules/mol)/(length of DNA in base pairs × 1 ×
109 ng/g × 650 g/mol). Duplicate, serial 10-fold dilutions
in uninfected canine gDNA (~10–30 ng/μl) resulted in
50–500,000 copies/reaction of plasmid DNA, and stand-
ard curves of quantification cycle (Cq) values were plotted
against the logarithm of plasmid copy numbers/reaction.
PCR efficiency was estimated through linear regression of
the dilution curve (10^ (-1/slope)-1) × 100). Coefficients
were calculated (R2) using Bio-Rad CFX Manager™ soft-
ware. Efficiency reactions were performed using both 2
and 3 primer reactions to establish any potential interfer-
ence by a third primer.
Analytical sensitivity and specificity
Analytical sensitivity was determined by calculating the
limit of detection (LOD), defined as the lowest concen-
tration at which 95% of the positive samples were de-
tected. Plasmids diluted in canine gDNA (~10–30 ng/μl)
to 1 copy/μl were added to reaction wells resulting in 3
and 5 copies/reaction. Twenty intra-assay replicates for
each plasmid concentration were tested and Cq ranges
determined. All assays were performed using both 2 and
3 primer reactions to establish any potential interference
by a third primer. Analytical specificity was evaluated
retrospectively using gDNA (~10–30 ng/μl) previously
extracted from bovine, canine, equine and feline EDTA-
whole blood specimens and tested by the VBDDL, deter-
mined to be either uninfected or infected with non-Babesia
vector-borne pathogens.
Clinical sensitivity and specificity
To determine relative clinical sensitivity and specificity,
the LSU qPCR was compared to an established Babesia
18S qPCR diagnostic assay that has been used for over
12 years. Retrospective and prospective testing was per-
formed. Retrospective analysis included 31 archived
gDNA samples, previously characterized as positive with
12 different Babesia spp. including B. bovis, B. caballi,
B. canis, B. rossi, B. vogeli, B. coco, B. conradae, B.
gibsoni, B. lengau, B. microti-like, B. odocoilei, and two
Babesia species in the Babesia (sensu stricto) clade, or C.
felis. After amplification with the LSU qPCR, one of each
of the 12-designated species from the retrospective
sample set was sequenced and aligned with a reference
sequence for species confirmation. Prospective analysis
included 394 canine diagnostic specimens submitted to
the VBDDL for testing using a comprehensive vector-
borne disease PCR panel, or when specifically requested,
Babesia PCR alone. All samples were simultaneously
tested using the 18S qPCR assay and the LSU qPCR
assay. Prospective specimens were tested at the time of
submission and all PCR positive results were speciated
with additional, species-specific PCRs targeting 18S
rRNA or the cox1 gene. In addition, any discordant PCR
Table 2 Primer combinations and concentrations used for
species of the genus Babesia and species-specific (sp-sp) PCRs
qPCR Primer combination (μM)
Babesia genus LSU qPCR B-lsu-F (0.6); B-lsu-R2 (0.6); Bmic-F (0.4)
Babesia genus 18S qPCR Bcommon-F (0.4); Bcommon-R (0.4)
B. microti-like sp-sp 18S qPCR BMIC18-F (0.8); BAB722 (0.8)
B. vogeli sp-sp 18S qPCR BCV-F (0.4); BAB722 (0.4)
B. canis sp-sp 18S qPCR BCC-F (0.4); BAB722 (0.4)
B. coco sp-sp 18S qPCR BCO-F (0.4); BAB722 (0.4)
B. gibsoni sp-sp 18S qPCR BGNC-F (0.4); BAB722 (0.4)
B. vogeli sp-sp cox1 qPCR BCV-cox1-F4 (0.4); BCV-cox1-R (0.4)
B. canis sp-sp cox1 qPCR BCC-cox1-F2 (0.4); BCC-cox1-R (0.4)
B. coco sp-sp cox1 qPCR BCO-cox1-F2 (0.4); BCO-cox1-R2 (0.4)
B. gibsoni sp-sp cox1 qPCR BG-cox1-F (0.4); BG-cox1-R (0.4)
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positive amplicons from the prospective study were se-
quenced to confirm results and were retested in triplicate
with both PCRs to account for the effect of Poisson distri-
bution on samples with low template concentrations.
Statistical analysis
Relative sensitivity and specificity for the 18S qPCR and
LSU qPCR were determined by a 2 × 2 table, calculating
an estimate of agreement relative to a non-reference
standard, either the 18S qPCR or the LSU qPCR [29].
Positive percent agreement (PPA), representing relative
sensitivity, was determined by the proportion of non-
reference standard positive samples where the index assay
is positive [a/(a + c)], and negative percent agreement
(NPA), representing relative specificity, was determined by
the proportion of non-reference standard negative sam-
ples where the index test is negative [d/(b + d)]. Ag-
reements and proportions were reported with their 95%
confidence intervals (95% CI), calculated by the
modified Wald method [30, 31]. Confidence intervals
were performed using GraphPad Software (La Jolla,
California, USA).
Results
qPCR efficiency, analytical sensitivity and specificity
Amplicon size for each primer pair was visualized on an
agarose gel and corresponded to the expected size of
~150 bp for most Babesia spp. and ~230 bp for B.
microti-like. Tm ranged from 76 to 77.5. LSU qPCR effi-
ciencies ranged from 92 to 100% with an R2 of 0.99 and
a linear dynamic range of 50–500,000 copies/reaction of
plasmid DNA (Table 3, Fig. 3). Results were comparable
when using either two primers (Bmic-F with B-lsu-R2
for B. microti-like plasmid template or B-lsu-F with B-
lsu-R2 for B. vogeli plasmid template) or three primers
(Bmic-F, B-lsu-F and B-lsu-R2) (Table 3). LODs were
initially tested at 3 copies/well using 20 intra-assay repli-
cates, with detection ranging from 60 to 90% (Table 3).
When the LOD was repeated at 5 copies/well, all reactions
showed 100% detection except the 3 primer B. microti-like
reaction (95% detection). Neither the LSU qPCR nor the
18S qPCR amplified uninfected mammalian host DNA.
The LSU qPCR did not amplify non-Babesia vector-borne
pathogens except for C. felis, and the 18S qPCR amplified
C. felis, H. canis and T. equi (Table 4).
Clinical sensitivity and specificity
Of the 31 archived, naturally-infected animal blood sam-
ples, previously characterized as containing 12 different
Babesia spp. or C. felis, 31/31 (100%) were LSU qPCR
positive and 26/31 (83.9%) were 18S qPCR positive
(Table 4). The sequenced LSU qPCR amplicons from 9/
12 Babesia species and C. felis were 100% identical with
GenBank reference sequences. Babesia lengau, B. odo-
coilei and Babesia (sensu stricto) mtDNA reference se-
quences were not available in GenBank for comparison
and were aligned with the lsu5-lsu4 region from other
Babesia mtDNA sequences (Fig. 2). Of the 26 concord-
ant samples, the average Cq value difference between the
two qPCRs (ΔCq = 18S qPCR Cq – LSU qPCR Cq) was
7.1. The LSU qPCR Cq was less than the 18S qPCR Cq
(representing earlier amplicon production) for B. bovis
(ΔCq = 15.2), B. coco (ΔCq = 6.9 and 7.0), B. conradae
(ΔCq = 13.5, 14.5, and 19.3), B. microti-like (ΔCq = 8.0,
8.4, and 8.7), B. lengau (ΔCq = 20.2) and C. felis (ΔCq = 14.2
and 14.6) (Fig. 4). Babesia odocoilei was the only Babesia
species in this sample set where the 18S qPCR amplified
DNA at a lower Cq (ΔCq = -10.7, -12.1 and -7.35) than the
LSU qPCR.
Of the 394 canine diagnostic specimens submitted for
vector-borne disease testing, 2.8% (11/394; 95% CI: 1.1–
4.4%) were Babesia-positive by the 18S qPCR and 4.8%
(19/394; 95% CI: 3.1–7.5%) were positive by the LSU
qPCR (Table 5). All but one of the positive samples were
speciated using species-specific PCRs targeting the 18S
rRNA or cox1 gene (Table 6). The Babesia spp. that
tested positive by both qPCR assays included B. canis
(n = 2), B. vogeli (n = 2) and B. gibsoni (n = 7) (Table 6).
Discordant results were obtained for 8 samples that
were 18S qPCR negative, but LSU qPCR positive, in-
cluding B. coco (n = 2), B. gibsoni (n = 5) and B. microti-
like (n = 1) (Table 6). All but one of the discordant
samples were confirmed by cox1 species-specific qPCRs
and amplicon sequencing of the LSU qPCR product. Two
Table 3 The efficiency and analytical sensitivity for the Babesia LSU qPCR. The efficiency and analytical sensitivity were determined
for the Babesia LSU qPCR using plasmids as template DNA run in 20 intra-assay replicates at 3 copies/well and 5 copies/well. Assays
were run with all 3 primers (Bmic-F, B-lsu-F and B-lsu-R2) for both plasmids and each corresponding 2 primer reaction: Bmic-F with
B-lsu-R2 for B. microti-like plasmid (pBMIC-LSU) and B-lsu-F with B-lsu-R2 for B. vogeli plasmid (pBCV-LSU)
Primers Plasmid template Eff (%) R2 3 c/well (%) Cq (range) 5 c/well (%) Cq (range)
2 primers pBMIC-LSU 100 0.99 90 34.1–37.2 100 33.5–37.5
3 primers pBMIC-LSU 95 0.99 70 33.6–37.3 95 34.2–37.8
2 primers pBCV-LSU 94 0.99 60 37.1–39.9 100 33.3–36.7
3 primers pBCV-LSU 92 0.99 60 36.8–39.2 100 33–34.2
Abbreviations:Eff efficiency, C copies
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of the discordant samples were also positive by 18S
species-specific qPCRs (Table 6). Of the discordant sam-
ples that were retested in triplicate with the LSU qPCR, 4
were positive in 3/3 replicates, 2 were positive in 2/3 repli-
cates, 1 was positive in 1/3 replicates and 1 was negative
in 3/3 replicates. For the 18S qPCR triplicate retest, 7
discordant samples were negative again in 3/3 replicates
and 1 (B. gibsoni) was positive in 1/3 replicates (Table 6).
Relative sensitivity and specificity between the 18S
qPCR and LSU qPCR were determined by calculating
the PPA and NPA for each assay [29] (Table 7). When
using the 18S qPCR as a non-reference standard, the
relative sensitivity (PPA) and specificity (NPA) of the
LSU qPCR was 100% (95% CI: 69.9–100%) and 98%
(95% CI: 95.9–99.0%), respectively. When using the LSU
qPCR as a non-reference standard, the relative sensitivity
(PPA) and specificity (NPA) for the 18S qPCR was 58%
(95% CI: 36.2–76.9%) and 100% (95% CI: 98.8–100%),
respectively.
Discussion
In this report, we describe the development and valid-
ation of a sensitive and specific broad-range molecular
diagnostic assay for detecting Babesia infections using a
three-primer qPCR assay targeting the mtDNA. Prior to
validation of the LSU qPCR, the VBDDL utilized a
qPCR targeting the 18S rRNA gene, optimized to detect
Babesia species infective to dogs, which included B.
canis, B. gibsoni, B. rossi and B. vogeli [15]. Since devel-
opment of the 18S qPCR assay, emerging Babesia spe-
cies have been discovered to infect dogs, including B.
conradae, B. microti-like and several large un-named
Babesia spp., designated B. coco [5–7]. Furthermore,
diagnostic laboratories, including NCSU-VBDDL, rou-
tinely test for emerging Babesia spp. in samples
collected from other animals, such as wildlife. At high
pathogen DNA quantities, the 18S qPCR can amplify
18S ribosomal DNA from these emerging species;
however, amplification efficiency is poor with lower
pathogen loads. Other Babesia diagnostic methods in-
clude testing with multiple, individual, species-specific
PCR assays, reverse line blotting, or nested PCR-
restriction fragment length polymorphism analysis.
These approaches are either costly, not as conducive to
a high throughput platform, or may not detect novel
Babesia pathogens [32, 33]. Screening diagnostic sam-
ples at the genus level using broad-range primers
followed by additional analysis of PCR positive samples,
such as species-specific PCRs and/or amplicon sequen-
cing to determine the species, supports a high thro-
ughput platform, is cost effective, and facilitates the
discovery of “new” pathogens. Identifying a DNA target
conserved among Babesia that contains hypervariable
sequences flanked by highly conserved sequences,
Fig. 3 Efficiency curves for the Babesia LSU qPCR using plasmids as template DNA. a B. microti-like plasmid (pBMIC-LSU) with 2 primers (Bmic_F
and B-lsu-R2). b pBMIC-LSU with 3 primers (Bmic-F, B-lsu-F and B-lsu-R2). c B. vogeli plasmid (pBCV-LSU) with 2 primers (B-lsu-F and B-lsu-R2). d
pBCV-LSU with 3 primers (Bmic-F, B-lsu-F and B-lsu-R2). Abbreviation: E, efficiency
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Table 4 Retrospective analysis qPCR results. Retrospective qPCRs were performed simultaneously on previously characterized
diagnostic or research samples from mammals that were uninfected (n = 4), naturally infected with Babesia or Cytauxzoon species
(n = 31) or other vector-borne pathogens (n = 13)
Characterized sample (source) Babesia 18S qPCR Babesia LSU qPCR
Cq Tm (°C) Cq Tm (°C)
B. bovis (cow) 32.2 86.5 17.0 76.5
B. caballi (horse) 29.4 86 29 77
B. caballi (horse) 36.3 86 35.1 76.5
B. canis (dog) 33.7 86 32.9 77
B. canis (dog) 36.7 86 36.8 77
B. canis (dog) 32.5 86 31.4 77
B. rossi (dog) 23.7 86 22.8 76.5
B. vogeli (dog) 21.9 86.5 20.5 77
B. vogeli (dog) 21.1 86 17.8 76.5
B. coco (dog) 34.7 86 27.8 77
B. coco (dog) 32.1 86 25.1 77
B. coco (dog) – none 40.6 77
B. conradae (dog) 34.2 86 19.8 76
B. conradae (dog) 39 86 19.7 76
B. conradae (dog) – none 17.3 76
B. conradae (dog) – none 21.4 76.5
B. gibsoni (dog) 13.2 86 13.01 77
B. gibsoni (dog) 19.3 86 19.2 77
B. lengau (leopard) 38.2 85.5 18 76
B. microti-like (dog) – none 30.8 77
B. microti-like (dog) – none 40.3 76.5
B. microti-like (dog) 32 86 24 76.5
B. microti-like (red fox) 36.5 85.5 27.8 76
B. microti-like (grey fox) 36.6 85.5 28.2 76
B. odocoilei (reindeer) 16.5 86 23.9 77
B. odocoilei (reindeer) 13.5 86.5 25.5 77
B. odocoilei (elk) 24.9 86.5 35.6 76.5
B. (sensu stricto) (maned wolf) 14.4 86 13.6 77
B. (sensu stricto) (bear) 34.1 86 32.4 76.5
Cytauxzoon felis (cat) 31.8 85.5 17.2 77.5
C. felis (cat) 35.3 85.5 21.2 77.5
Uninfected gDNA (cat) – none – none
Uninfected gDNA (cow) – none – none
Uninfected gDNA (dog) – none – none
Uninfected gDNA (horse) – none – none
Anaplasma phagocytophilum (dog) – none – none
A. platys (dog) – none – none
Bartonella henselae (cat) – none – none
Ehrlichia canis (dog) – none – none
E. ewingii (dog) – none – none
Hepatozoon canis (dog) 39.0 85 – none
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where primers do not amplify other eukaryotic DNA
can be challenging. The LSU qPCR assay amplifies a
region of DNA spanning two large ribosomal subunits,
lsu5-lsu4, that is conserved among piroplasmida indi-
cating it is less likely to be deleted or changed due to
DNA rearrangements or mutations [26–28]. This study
demonstrated an increased level of relative sensitivity
and a broader range of Babesia spp. detection when the
LSU qPCR was compared to an established molecular
diagnostic assay. There was improved detection when
testing animal samples naturally infected with B. bovis,
B. coco, B. conradae, B. lengau, and B. microti-like
organisms. While we did not include a C. felis mtDNA
sequence (GenBank accession no. KC207821) in the
Babesia alignment used to design new primers, the B-
lsu-F and B-lsu-R2 primers are 100% identical to the
corresponding sequences of the C. felis lsu5-lsu4 region
and amplified this feline pathogen. For differentiation
of C. felis from Babesia spp., the authors recommend
either amplicon sequencing or testing the sample with
a validated C. felis species-specific PCR [17].
The Cq differences (ΔCq = 18S qPCR Cq - LSU qPCR
Cq) between the 18S qPCR and the LSU qPCR have
several possible explanations (Table 1, Fig. 4). It is pos-
sible the noted differences were due in part to differing
primer efficiencies and not necessarily related to target
DNA copy number. Primer alignments using the 18S
qPCR primers, Bcommon-F (bp = 24) and Bcommon-R
(bp = 29), revealed base pair mismatches were greatest
with the Bcommon-F primer in B. conradae (9/24) B.
lengau (8/24), B. microti-like (7/24), and C. felis (9/24),
while all the other Babesia spp. in the retrospective sam-
ple set had bp mismatches ≤ five (Fig. 5). Except for B.
microti and B. microti-like, where a different forward
primer is used for the LSU qPCR target, the B-lsu-F
primer has only two mismatches with B. canis and B.
vogeli. However, these mismatches are mitigated with
two degenerate primer nucleotides (Fig. 2). The B-lsu-R2
Table 4 Retrospective analysis qPCR results. Retrospective qPCRs were performed simultaneously on previously characterized
diagnostic or research samples from mammals that were uninfected (n = 4), naturally infected with Babesia or Cytauxzoon species
(n = 31) or other vector-borne pathogens (n = 13) (Continued)
H. americanum (dog) – none – none
Leishmania infantum (dog) – none – none
Mycoplasma hemocanis (dog) – none – none
Neorickettsia risticii (culture) – none – none
Rickettsia rickettsii (dog) – none – none
Theileria equi (horse) 38.9 86 – none
Trypanosoma cruzi (dog) – none – none
Abbreviations: Cq quantification cycle, Tm melting temperature; −, Babesia was not amplified
Fig. 4 Comparison of the ΔCq from retrospective 18S qPCR and LSU
qPCR assays performed simultaneously on previously characterized
diagnostic or research samples naturally infected with Babesia spp.
and C. felis. n/a = sample was negative by 18S qPCR and positive in
LSU qPCR; ΔCq = Cq 18S qPCR – Cq LSU qPCR
Table 5 Positive LSU qPCR results were compared with 18S
qPCR results from a prospective analysis performed on canine
diagnostic samples naturally infected with Babesia spp.
Total samples (n = 394) 18S LSU
B. canis (+) 2 2
B. vogeli (+) 2 2
B. coco (+) 0 2
B. gibsoni (+) 7 12
B. microti-like (+) 0 1
% Positive (95% CI) 2.8 (1.1–4.4%) 4.8 (3.1–7.5%)
(+) = Cq value obtained, Tm value was correct
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primer (bp = 22) has no mismatches except one in B.
divergens and two in B. microti and B. microti-like.
A large prospective set of samples from dogs sus-
pected of exposure to vector-borne pathogens was used
to measure relative sensitivity and specificity between an
established diagnostic qPCR and a newly developed
qPCR. The newly developed LSU qPCR relative sensitiv-
ity was 100% when compared to the established 18S
qPCR, while the 18S qPCR relative sensitivity was 58%
when compared to the LSU qPCR, suggesting the new
assay is more sensitive at detecting Babesia. The LOD
for the LSU qPCR assay was determined to be ~ five
copies/reaction while the established Babesia 18S rDNA
was determined to be between five and ten copies/reac-
tion (data not included); both LODs were determined
using plasmids containing one copy of the target DNA
diluted in canine gDNA. Making direct comparisons be-
tween LODs with other qPCRs reported in the literature
using similar methods of calculation show the LSU and
18S qPCRs to be comparable. One assay targeting B.
canis hsp70 calculated a LOD at ~ ten copies using a
probe for detection [12]; another qPCR assay targeting
Table 6 Prospective analysis was performed on canine diagnostic samples naturally infected with Babesia spp. and quantification
cycles (Cq) were compared between the 19 positive samples detected by Babesia genus assays (18S qPCR or LSU qPCR) and species-specific
assays (18S sp-sp or cox1 sp-sp). Results are shown from the original Babesia genus qPCRs, discordant samples that were
repeated in triplicate with the Babesia genus qPCRs, and Babesia species-specific qPCRs. All positive samples generated the
correct melting temperature (Tm) values (not shown)
Genus level qPCR Species-specific qPCR
Original results Repeated results (triplicate)
Babesia spp. 18S LSU 18S LSU 18S cox1
B. canis 31.4 30.5 na na 31.6 30.0
B. canis 31.7 29.9 na na 31.8 31.3
B. vogeli 30.6 29.4 na na 31.3 31.4
B. vogeli 32.1 32.1 na na 31.1 31.7
B. gibsoni 13.8 13.9 na na 14.8 16.3
B. gibsoni 17.7 19.6 na na 19.5 22.9
B. gibsoni 19.6 18.0 na na 21.8 24.4
B. gibsoni 21.6 22.2 na na 30.1 23.0
B. gibsoni 29.2 30.4 na na 29.2 30.8
B. gibsoni 18.0 18.0 na na 19.3 19.7
B. gibsoni 13.5 13.3 na na 14.5 15.8
B. coco – 39.8 – 38.5; 38.6; 33.8 – 39.0
B. coco – 38.2 – 39.2; 33.1; − – 36.0
B. gibsoni – 37.5 – – – –
B. gibsoni – 39.4 – 40.7; 38.3; 38.4 39 37.0
B. gibsoni – 30.9 – 29.4; 29.7; 30.6 – 31.1
B. gibsoni – 39.0 37.0; −; − 38.4; −; − – 36.2
B. gibsoni – 38.4 – 39.5; 38.6; − – 39.0
B. microti-like – 29.0 – 31.0; 30.6; 30.3 32 na
Abbreviations: na, the sample was not retested; −, Babesia was not amplified
Table 7 Positive percent agreement (PPA) and negative percent
agreement (NPA)
Positive Negative Row sum
LSU qPCR (index) 18S qPCR (non-reference standard)
Positivea 11 8 19
Negativeb 0 375 375
Column sum 11 383 394
18S qPCR (index) LSU qPCR (non-reference standard)
Positivec 11 0 11
Negatived 8 375 383
Column sum 19 375 394
Note: We calculated PPA and NPA using 18S qPCR assay (top) or LSU qPCR
assay as the non-reference standard
aPPA = 100% (95% CI: 69.9–100%)
bNPA = 98% (95% CI: 95.9–99.0%)
cPPA = 58% (95% CI: 36.2–76.9%)
dNPA = 100% (95% CI: 98.8–100%)
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B. microti 18S rDNA calculated ~3.6 copies per reaction
using blood spiked with plasmid DNA [34]. Both the
LSU and 18S qPCR assays had high specificities relative
to each other, with the 98% specificity reported for LSU
qPCR reflecting the positive discordant samples not
detected by the 18S qPCR.
When comparing results from naturally infected ca-
nine samples used for the prospective study, eight
samples were PCR negative by the 18S qPCR but
positive by the LSU qPCR (Table 7). It is unclear if
this difference in sensitivity is related to improved
primer binding and subsequent amplification, in-
creased target copy number, or clinical status of the
patient at time of sampling (treated or untreated). It’s
possible mtDNA copy numbers vary among Babesia
species or stages of piroplasmida infection. Schreeg et
al. detected higher mtDNA copy numbers in cats
acutely infected with C. felis when compared to cats
infected over a year [17]. It remains unclear if there
is a link between the mtDNA copy number and stage
of Babesia infection.
Limitations of this study include the inability to cal-
culate true sensitivity and specificity for the new LSU
qPCR assay and that the new assay was only com-
pared to one other qPCR assay. However, in both the
prospective and retrospective sample sets, the LSU
qPCR outperformed the 18S qPCR. While reasons
behind this improvement remain unclear, we hypoth-
esis that increased target copy number for the mito-
chondrial PCR is a contributing factor.
Conclusions
In summary, we have developed a qPCR assay with
increased sensitivity to detect a broader number of
Babesia spp. The LSU qPCR targets a highly conserved
region of the mtDNA spanning the lsu5-lsu4 region.
Retrospective and prospective analysis with samples
from naturally infected animals highlight the expansive
range of Babesia spp. detection and improved relative
sensitivity when compared to a current 18S qPCR.
Currently the VBDDL has implemented the new LSU
qPCR assay for all diagnostic Babesia PCRs and con-
firms all positive samples with a second species-specific
qPCR, targeting either the 18S rRNA or cox1 genes.
Samples from ungulates are also screened with the 18S
qPCR for improved detection of B. odocoilei.
Abbreviations
18S qPCR: qPCR assay targeting a region of the 18S rRNA gene in Babesia
spp.; Cq: Quantification cycle; EDTA: Ethylenediamine tetraacetic acid;
gDNA: Genomic DNA; LSU qPCR: qPCR assay targeting a region of the large
subunit rRNA gene fragments lsu5- lsu4 on the mtDNA of Babesia spp.;
mtDNA: Mitochondrial DNA; NPA: Negative percent agreement; PPA: Positive
percent agreement; qPCR: Quantitative real-time polymerase chain reaction;
Tm: Melting temperature; VBDDL: Vector-Borne Disease Diagnostic Laboratory
Fig. 5 Sequence alignment of the 18S rRNA gene from representative Babesia spp., Cytauxzoon felis and primers designed for use in the Babesia
18S qPCR assay. The GenBank accession numbers are shown in parentheses
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